Clinical and demographic characteristics of patients (pts) treated with vemurafenib in real-world setting

被引:0
|
作者
Sadetsky, N. [1 ]
Corvino, F. [2 ]
Surinach, A. [2 ]
Goodman, G. [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Genesis Res LLC, Hoboken, NJ USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P062
引用
收藏
页码:E42 / E42
页数:1
相关论文
共 50 条
  • [41] Clinical characteristics and sick leave associated with infectious mononucleosis in a real-world setting in Germany
    Kap, Elisabeth J.
    Konrad, Marcel
    Kostev, Karel
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021,
  • [42] Real-world evidence and clinical characteristics in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI)
    Iranzo, P.
    Callejo, A.
    Marmolejo, D.
    Assaf, J. D.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Cedres, S.
    Diaz Mejia, N. M.
    Carbonell, C.
    Amat, R.
    Frigola, J.
    Felip, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S767 - S767
  • [43] QUALITY OF LIFE OF PATIENTS TREATED FOR MULTIPLE MYELOMA (MM) IN FRANCE IN A REAL-WORLD SETTING
    Despiegel, N.
    Touboul, C.
    Flinois, A.
    Saba, G.
    Gonzalez-McQuire, S.
    Suzan, F.
    Blachier-Poisson, C.
    Guilhaume, C.
    VALUE IN HEALTH, 2016, 19 (07) : A383 - A383
  • [44] PREDICTORS OF RESPONSE IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH INFLIXIMAB OR GOLIMUMAB IN A REAL-WORLD SETTING
    Bessette, L.
    Kapur, S.
    Zummer, M.
    Starr, M.
    Choquette, D.
    Sheriff, M.
    Olszynski, W.
    Rampakakis, E.
    Psaradellis, E.
    Osborne, B.
    Maslova, K.
    Nantel, F.
    Lehman, A. J.
    Tkaczyk, C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1131 - 1131
  • [45] Predictors of Response in Patients with Ankylosing Spondylitis Treated with Infliximab or Golimumab in a Real-World Setting
    Bessette, Louis
    Kapur, Suneil
    Zummer, Michel
    Starr, Michael
    Choquette, Denis
    Sheriff, Maqbool
    Olszynski, Wojciech
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Osborne, Brendan
    Maslova, Karina
    Nantel, Francois
    Lehman, Allen
    Tkaczyk, Cathy
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1197 - 1197
  • [46] Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting
    Fonseca, Eduardo
    Iglesias, Raquel
    Paradela, Sabela
    Fernandez-Torres, Rosa M.
    Elberdin, Laida
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (03) : 217 - 222
  • [47] Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
    Alabduljabbar, Khaled
    Alsaqaaby, Moath
    Neff, Karl J.
    Crotty, Michael
    le Roux, Carel W.
    ENDOCRINE, 2024, 83 (02) : 392 - 398
  • [48] Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
    Khaled Alabduljabbar
    Moath Alsaqaaby
    Karl J. Neff
    Michael Crotty
    Carel W. le Roux
    Endocrine, 2024, 83 : 392 - 398
  • [49] Prevalence, Characteristics, and Clinical Burden among Patients with Overweight or Obesity and Established ASCVD in a US Real-World Setting
    Michalak, Wojciech
    Boame, Nana
    Zhao, Xin
    Lamarre, Neil
    Rava, Andrew
    Doan, Quan V.
    Faurby, Mads
    Hartaigh, Briain O.
    Fabricatore, Anthony
    Zhao, Zhenxiang
    DIABETES, 2024, 73
  • [50] Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world setting
    Buysman, Erin K.
    Chow, Wing
    Henk, Henry J.
    Rupnow, Marcia F. T.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (01) : 137 - 143